John S Yu
CIK 1550545 · CEO and Chairman · last filed 2025-11-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.44M
Companies
3
Total Filings
14
Lifetime Open-Market Net
-$865.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KAPA | CEO and Chairman | 5,546,677 | $0.44 | $2.44M | $5.8K | 3 | 2025-11-26 |
| ImmunoCellular Therapeutics, Ltd. (IMUC.WS) Delisted | Director | 120,508 | — | — | $0 | 1 | 2018-06-08 |
| ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Secretary | 30,652 | — | — | -$871.2K | 10 | 2016-06-21 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-10-22 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Mixed | — | -$711.5K | EDGAR |
| 2013-09-24 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-06-17 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-12-18 | ImmunoCellular Therapeutics, Ltd. (IMUC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.